Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.49% | 15.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.33% | 10.24% | |||
| Operating Income | 2.33% | -10.24% | |||
| Income Before Tax | 2.85% | -12.73% | |||
| Income Tax Expenses | -13.73% | 96.15% | |||
| Earnings from Continuing Operations | 2.87% | -12.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.87% | -12.80% | |||
| EBIT | 2.33% | -10.24% | |||
| EBITDA | 2.34% | -10.25% | |||
| EPS Basic | 9.21% | -12.31% | |||
| Normalized Basic EPS | 10.48% | -12.23% | |||
| EPS Diluted | 9.21% | -12.31% | |||
| Normalized Diluted EPS | 10.48% | -12.23% | |||
| Average Basic Shares Outstanding | 6.98% | 0.44% | |||
| Average Diluted Shares Outstanding | 6.98% | 0.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||